Restoring the Balance: CRISPRa-Driven β-Tubulin Compensation as a Strategy for Tubulinopathy Treatment
International Journal of Molecular Sciences · 03.08.2026 · 27 (15) · 6954
DOI: 10.3390/ijms27156954 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.08.2026. Verfasst von Sydney Steiman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada. Hauptthemen laut MEDLINE: Tubulin, CRISPR-Cas Systems, Gene Editing, Ciliopathies. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nicol Family Foundation, SickKids Research Training Centre, Canadian Institutes of Health Research (CIHR)-REDI.
Abstract (Originalsprache)
Microtubules are essential cytoskeletal components comprising alpha- and beta-tubulin proteins that facilitate organelle positioning, cell migration, division, and intracellular trafficking. Mutations in tubulin genes can lead to tubulinopathies, a class of rare genetic neurodevelopmental disorders characterized by a range of brain malformations and other clinical features. Recent studies have shown that pathogenic variants in beta-tubulin genes such as TUBBG308S have been found to underlie the development of ciliopathies, disorders impacting cilia, important organelles for development and cell motility. Thus, mutations in distinct tubulin genes, which present a significant hurdle for the development of therapeutic gene editing strategies and targeted therapeutics. Here, we describe the development of a mutation-independent treatment strategy based on the upregulation of non-mutated beta-tubulin isotype protein using CRISPR-Cas9 activation. By increasing the expression of various beta-tubulin proteins, we demonstrate a restoration of the microtubule network and primary cilia formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
- Department of Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
- Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, Canada.
- Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
Förderung
- Nicol Family Foundation
- SickKids Research Training Centre
- Canadian Institutes of Health Research (CIHR)-REDI
- Restracomp Fellowship
- BluGenes Foundation
Zitieren
APA
Steiman, S., Kinsella, C., Zhang, Y., Omer, S., Brown, C., Forguson, G., Elbakr, L., Pastore, S., & Ivakine, E. A. (2026). Restoring the Balance: CRISPRa-Driven β-Tubulin Compensation as a Strategy for Tubulinopathy Treatment. International Journal of Molecular Sciences, 27(15), 6954. https://doi.org/10.3390/ijms27156954
Vancouver
Steiman S, Kinsella C, Zhang Y, Omer S, Brown C, Forguson G, et al. Restoring the Balance: CRISPRa-Driven β-Tubulin Compensation as a Strategy for Tubulinopathy Treatment. International Journal of Molecular Sciences. 2026;27(15):6954. doi:10.3390/ijms27156954
BibTeX
@article{Steiman2026,
author = {Steiman, Sydney and Kinsella, Ciara and Zhang, Yixiang and Omer, Safia and Brown, Cadence and Forguson, Georgiana and Elbakr, Lujaina and Pastore, Stephen and Ivakine, Evgueni A},
title = {Restoring the Balance: CRISPRa-Driven β-Tubulin Compensation as a Strategy for Tubulinopathy Treatment},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6954},
doi = {10.3390/ijms27156954}
}
EUVIMED